Cancer medicine generates enormous revenues but marginal benefits for patients?
This article is absolute 100% bullshit.<p>-Metastatic melanoma: used to be lethal, now 50% cure rate.[1]<p>-Non small cell lung cancer: same, now around 25% [2, 4]<p>-Breast cancer used to have a terrible prognisis, now 75% survive. [3]<p>-Not to mention the myriad of blood cancers with new, strong, cell therapy treatment options with 40-50% durable cure rate.<p>I don't know this person, but seriously, whoever he is, fuck you dude. Millions of us work day and night trying to improve care, and 99% of us arent getting rich.<p>[1] <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1709684" rel="nofollow">https://www.nejm.org/doi/full/10.1056/NEJMoa1709684</a><p>[2] <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1801946" rel="nofollow">https://www.nejm.org/doi/full/10.1056/NEJMoa1801946</a><p>[3] <a href="https://www.breastcancer.org/research-news/20100930" rel="nofollow">https://www.breastcancer.org/research-news/20100930</a><p>4. <a href="https://investors.merck.com/news/press-release-details/2019/Five-Year-Survival-Data-for-Mercks-KEYTRUDA-pembrolizumab-in-Advanced-Non-Small-Cell-Lung-Cancer-NSCLC-from-First-KEYNOTE-Trial-at-2019-ASCO-Annual-Meeting/default.aspx" rel="nofollow">https://investors.merck.com/news/press-release-details/2019/...</a>